Top down treatment if patient at high risk ( DrugBank: - )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
96	Crohn disease	1
97	Ulcerative colitis	1

96. Crohn disease

---

Clinical trials : 2,442 /  Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05180175 (ClinicalTrials.gov)	February 7, 2022	17/12/2021	The Nordic IBD Treatment Strategy Trial	The Nordic IBD Treatment Strategy Trial- a Randomised Controlled Trial of Access to a Protein Profile	Inflammatory Bowel Diseases;Ulcerative Colitis;Crohn Disease	Drug: Top down treatment if patient at high risk	Region Örebro County	NULL	Recruiting	18 Years	70 Years	All	250	Phase 4	Denmark;Iceland;Norway;Sweden

97. Ulcerative colitis

---

Clinical trials : 2,630 /  Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05180175 (ClinicalTrials.gov)	February 7, 2022	17/12/2021	The Nordic IBD Treatment Strategy Trial	The Nordic IBD Treatment Strategy Trial- a Randomised Controlled Trial of Access to a Protein Profile	Inflammatory Bowel Diseases;Ulcerative Colitis;Crohn Disease	Drug: Top down treatment if patient at high risk	Region Örebro County	NULL	Recruiting	18 Years	70 Years	All	250	Phase 4	Denmark;Iceland;Norway;Sweden